9 Honest Facts About Ashwagandha Before Menopausal Women Use It for Stress and Sleep
The number of times ashwagandha gets mentioned in perimenopause forums as a cure-all is genuinely staggering. What rarely gets mentioned alongside it is the thyroid piece — and for women already navigating hormone chaos, that detail matters more than any marketing copy will tell you.
Learn more about Rose →It Has Legitimate Evidence for Reducing Perceived Stress — Within Limits
Several randomized controlled trials have found that ashwagandha root extract (typically 300–600 mg daily) meaningfully reduces self-reported stress and anxiety compared to placebo over 8–12 weeks. The most-cited 2019 study in Medicine showed significant reductions in perceived stress scores and serum cortisol in chronically stressed adults. The catch: most trials are small, industry-funded, and use proprietary extracts — so the effect size in real-world use may be more modest than headlines suggest.
Its Cortisol-Lowering Effect Is Real but Not Dramatic
Ashwagandha does appear to modestly reduce morning serum cortisol in people with elevated baseline stress — reductions of roughly 14–32% have been reported across trials. This matters in perimenopause because cortisol dysregulation worsens sleep, amplifies hot flushes, and competes with progesterone production. However, it is not a cortisol 'reset' and will not compensate for chronic sleep deprivation, unmanaged psychological stress, or significant HPA axis dysfunction on its own.
It Can Affect Thyroid Hormone Levels — and That Matters in Midlife
Ashwagandha has been shown in multiple studies to increase T3 and T4 thyroid hormone levels, likely by stimulating thyroid activity through its withanolide compounds. For women who are already hypothyroid and on levothyroxine, this could alter medication requirements; for those with subclinical hyperthyroidism or Hashimoto's, it could tip the balance in the wrong direction. Thyroid dysfunction is disproportionately common in perimenopausal women, which makes this interaction worth discussing with a GP before starting.
The Sleep Benefits Are Probably Real — and Likely Linked to a Specific Compound
A 2020 randomized trial published in PLOS ONE found that ashwagandha root extract significantly improved sleep quality, sleep onset latency, and next-morning alertness compared to placebo after eight weeks. The mechanism appears to involve triethylene glycol, a compound in the leaves and root, which has shown sleep-inducing properties in animal models through GABA-pathway activity. This is a plausible, physiologically grounded reason to consider it for sleep — not just vague 'adaptogenic' claims.
It Is Not a Hormonal Supplement — But It Does Interact With the Endocrine System
Ashwagandha does not contain estrogen or progesterone, and it is not a phytoestrogen in the way that red clover or soy isoflavones are. However, it does interact with the broader endocrine system — influencing cortisol, thyroid hormones, and in some animal studies, reproductive hormones including DHEA. Women using hormone therapy should be aware that adaptogen-driven endocrine activity, even if subtle, adds another variable to an already complex hormonal picture.
Liver Injury Cases Have Been Reported — Rare but Worth Knowing
A small number of case reports, including cases reviewed by the European Medicines Agency, have documented drug-induced liver injury (DILI) associated with ashwagandha supplementation. The cases generally resolved after stopping the supplement, and the absolute risk appears low, but the signal is real enough that it is included in pharmacovigilance databases. Women with existing liver conditions, or those taking medications with hepatic metabolism, should factor this in and avoid high doses taken long-term without breaks.
Dose and Extract Type Make a Significant Difference to Outcomes
Not all ashwagandha products are equivalent — full-spectrum root extract, root-and-leaf combinations, and isolated withanolide-standardized extracts behave differently in the body. Most positive trial data comes from standardized root extracts at 300–600 mg daily; products using generic 'ashwagandha powder' at unclear concentrations have a much weaker evidence base. This is one supplement category where understanding what is actually in a product matters more than most, and where the gap between a studied extract and an unstandardized capsule is genuinely wide.
It Has a Reasonable Safety Profile for Short-Term Use — Long-Term Data Are Thin
The available clinical trials mostly run for 8–12 weeks, and within those windows ashwagandha is generally well tolerated with mild side effects such as loose stools or mild drowsiness reported in some participants. What is genuinely unknown is whether daily use over one to three years carries the same safety profile — that data simply does not exist yet. A sensible approach, consistent with traditional Ayurvedic use, is cycling the supplement rather than taking it continuously without breaks.
It Is Not a Substitute for Addressing the Root Causes of Perimenopausal Sleep Loss and Stress
Ashwagandha cannot replace estrogen that is no longer being produced, repair sleep architecture disrupted by night sweats, or resolve the psychological load of midlife transition. The evidence supports it as a modest, adjunctive tool — most useful in women whose stress and sleep issues are driven primarily by HPA axis dysregulation rather than primarily by estrogen or progesterone loss. Using it as a first-line intervention while avoiding conversations about hormone therapy, cognitive behavioural therapy for insomnia, or lifestyle factors is a pattern worth being honest about.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.